The company will also display its new instrument, the Sequel™ System, which was launched yesterday. The Sequel System provides higher throughput, more scalability, a reduced footprint and lower sequencing project costs compared to the PacBio® RS II System, while maintaining the existing benefits of the company’s SMRT Technology.
“We are excited to support the human genetics community as they pursue the generation of higher-quality whole human genomes, and move beyond SNPs to sequence the full size-spectrum of human genetic variation,” said
The company will host a workshop titled “Addressing Hidden Heritability through Long-Read Single Molecule, Real-Time (SMRT) Sequencing” on
The depth and breadth of scientific talks presented at ASHG this year demonstrate how long-read SMRT Sequencing is opening up new frontiers by helping the genome sequencing community create gold-standard genome references, characterize complex regions, resolve structural variation, and unlock isoform diversity. Highlights include the following podium presentations:
Long read single-molecule real-time (SMRT) full gene sequencing of cytochrome P450 2D6 (CYP2D6) #27
Comprehensive genome and transcriptome structural analysis of a breast cancer cell line using PacBio long read sequencing #14
Evolution and structural diversity of the complement factor H related gene cluster #47
Building a platinum assembly from single haplotype human genomes generated from long molecule sequencing #227
Building a Better Human Genome Reference and Targeting Structure using SingleMoleculeTechnologies #228
Genome in a Bottle: You may have sequenced, but how well did you do? #229
A Diploid Personal Human Genome Reference from Diverse Sequence Data – A Model for Better Genomes #232
Full-length mRNA sequencing uncovers a widespread coupling between transcription and mRNA processing #71
Research conducted using SMRT Sequencing will also be featured in at least 28 poster presentations. A full list of PacBio-related ASHG meeting research and activities is available here. Attendees can also visit the PacBio booth (#907).
About Pacific Biosciences
combination with the ability to detect real-time kinetic information. The Sequel System, including consumables and software, provides a simple, fast, end-to-end workflow for SMRT Sequencing. More information is available at www.pacb.com.
All statements in this press release that are not historical are forward-looking statements, including, among other things, statements relating to the attributes of the Sequel System, future commercialization, uses and performance of the company’s products, and other future events. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties, changes in circumstances and other factors that are, in some cases, beyond Pacific Biosciences’ control and could cause actual results to differ materially from the information expressed or implied by forward-looking statements made in this press release. Factors that could materially affect actual results can be found in Pacific Biosciences’ most recent filings with the
10-K and 10-Q, and include those listed under the caption “Risk Factors.” Pacific Biosciences undertakes no obligation to revise or update information in this press release to reflect events or circumstances in the future, even if new information becomes available.
CONTACT: For Pacific Biosciences: Media:
Nicole Litchfield415.793.6468 firstname.lastname@example.org Investors: Trevin Rard650.521.8450 email@example.com
News Provided by Acquire Media